Search results for "Highlights"


 
Results 141 - 150 of about 446 for "Highlights".
Sort by: Relevance | Newest | Oldest

Thiazolidinedione add-ons associated with less CV risk, study finds

The U.K.-based retrospective cohort study used a database that linked national hospitalization and mortality data for people who were prescribed second-line regimens after metformin.
https://diabetes.acponline.org/archives/2016/07/15/2.htm
15 Jul 2016

Very low systolic blood pressure associated with less CV risk in diabetes patients

Patients with type 2 diabetes and a systolic blood pressure of 110 to 119 mm Hg appeared to have a lower risk of cardiovascular disease than patients who had systolic blood pressures of 130 to 139 mm Hg, according to a registry study.
https://diabetes.acponline.org/archives/2016/08/12/3.htm
12 Aug 2016

Incretin-based drugs not associated with higher risk of pancreatitis in large, population-based study

The findings of this study should provide some reassurance to patients treated with incretin-based drugs, according to the authors.
https://diabetes.acponline.org/archives/2016/08/12/2.htm
12 Aug 2016

HbA1c variability linked to risk of adverse long-term outcomes in type 2 diabetes

The effect of HbA1c variability on outcomes, including mortality, myocardial infarction, and stroke, appeared to be independent of directional trends or baseline HbA1c level.
https://diabetes.acponline.org/archives/2016/08/12/1.htm
12 Aug 2016

Intense multifactorial intervention associated with increased life span, time to CVD events in type 2 diabetes

The intensive intervention was initially conducted for a median of 7.8 years and used both pharmacologic and behavioral methods to target coexisting risk factors for late complications of diabetes.
https://diabetes.acponline.org/archives/2016/09/16/2.htm
16 Sep 2016

Restricting orders for insulin glargine may lower hypoglycemia rates, study finds

Non-endocrinologist clinicians who electronically ordered glargine at a dose of 0.5 units/kg or greater incurred a warning screen, which advised either lowering the dose or contacting the diabetes consult service for approval.
https://diabetes.acponline.org/archives/2016/09/16/3.htm
16 Sep 2016

CABG may improve outcomes compared with PCI in patients with diabetes and stable CAD

The results support coronary artery bypass grafting (CABG) with optimal medical therapy as the preferred management strategy, with optimal medical therapy alone as the next best therapeutic approach, the study authors said.
https://diabetes.acponline.org/archives/2016/09/16/1.htm
16 Sep 2016

Weekly GLP-1 analogue associated with reduced MI, stroke risk, industry study finds

The trial of semaglutide included 3,297 patients with type 2 diabetes, 83% of whom had established cardiovascular disease, chronic kidney disease, or both.
https://diabetes.acponline.org/archives/2016/10/07/3.htm
7 Oct 2016

3 biomarkers may refine standard cardiovascular risk algorithms for diabetes

Elevations in high-sensitivity troponin T or N-terminal pro-B-type natriuretic peptide were significantly associated with risk of cardiovascular death, myocardial infarction, and hospitalization for heart failure, while C-reactive protein was a less significant predictor.
https://diabetes.acponline.org/archives/2016/10/07/2.htm
7 Oct 2016

Spotlight on new technologies for type 1 diabetes

Two recent studies and FDA approval of the first “artificial pancreas” highlight new technological advances in type 1 diabetes care.
https://diabetes.acponline.org/archives/2016/10/07/8.htm
7 Oct 2016

Result Page: Prev   10   11   12   13   14   15   16   17   18   19   Next